Yunteng Wu

1 article listing Yunteng Wu in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Dalpicilib combined with cetuximab in patients with HPV-negative, anti-PD-1-resistant recurrent or metastatic head and neck squamous cell carcinoma: A phase II trial Nature Communications